ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Serono S A

Serono S A (SRA)

0,00
0,00
(0,00%)
Beim Schlusskurs: 23 Januar 10:00PM
0,00
0,00
( 0,00% )
Nach Börsenschluss: -

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
-
Gebot
-
Fragen
-
Volumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Handelsende
-
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Durchschnittliches Volumen (3 Mio.)
-
Finanzvolumen
-
VWAP
-

SRA Neueste Nachrichten

Merck Serono and Domain Therapeutics Announce an Agreement to Develop Drugs for Parkinson's Disease

Merck Serono and Domain Therapeutics Announce an Agreement to Develop Drugs for Parkinson's Disease - Merck Serono to Develop Domain Therapeutics' mGluR4 Allosteric Modulators PR Newswire GENEVA...

Brighter Futures in MS - Inspiring Short Film Premieres in Brussels

Brighter Futures in MS - Inspiring Short Film Premieres in Brussels PR Newswire GENEVA and BRUSSELS, January 12, 2011 GENEVA and BRUSSELS, January 12, 2011 /PRNewswire/ -- Merck Serono, a...

Merck Serono and San Raffaele Scientific Institute to Collaborate on Research in Neurodegenerative Diseases

Merck Serono and San Raffaele Scientific Institute to Collaborate on Research in Neurodegenerative Diseases PR Newswire GENEVA, December 13, 2010 GENEVA, December 13, 2010 /PRNewswire/ -- Merck...

Merck Serono Announces Extension of FDA Priority Review Period for Cladribine Tablets for the Treatment of Relapsing Forms of Mu

Merck Serono Announces Extension of FDA Priority Review Period for Cladribine Tablets for the Treatment of Relapsing Forms of Multiple Sclerosis - FDA Extends Priority Review period of Cladribine...

Merck Serono: Enrollment Completed for ORACLE MS Study of Cladribine Tablets in Patients at Risk of Developing MS

Merck Serono: Enrollment Completed for ORACLE MS Study of Cladribine Tablets in Patients at Risk of Developing MS PR Newswire GENEVA, November 17, 2010 GENEVA, November 17, 2010 /PRNewswire/...

Merck Serono: Ready-to-Use Formulation of Recombinant Growth Hormone Saizen Recommended for Approval in Europe

Merck Serono: Ready-to-Use Formulation of Recombinant Growth Hormone Saizen Recommended for Approval in Europe - Saizen(R) Solution For Injection Eliminates the Need to Reconstitute Powder for...

Merck Serono Announces Top-Line Results of Long-Term Study of Safinamide as Add-on Treatment to Levodopa in Advanced Parkinson's

Merck Serono Announces Top-Line Results of Long-Term Study of Safinamide as Add-on Treatment to Levodopa in Advanced Parkinson's Disease PR Newswire GENEVA, Switzerland, November 4, 2010 GENEVA...

Merck Serono Sells Théramex to Teva for EUR 265 Million

Merck Serono Sells Théramex to Teva for EUR 265 Million - Acquisition Will Provide Teva With a Strong Platform to Expand its Global Women's Health Business - Merck Serono to Maintain Focus on its...

Merck Serono: REFLEX Study Results Show Treatment With Rebif(R) Delays Conversion to MS in Patients With First Clinical Signs of

Merck Serono: REFLEX Study Results Show Treatment With Rebif(R) Delays Conversion to MS in Patients With First Clinical Signs of the Disease - Study Met its Primary Endpoint - Risk of Converting...

Merck Serono to Introduce RebiDose(TM), the Rebif(R) Single Use Pre-filled Pen for Treatment of Multiple Sclerosis

Merck Serono to Introduce RebiDose(TM), the Rebif(R) Single Use Pre-filled Pen for Treatment of Multiple Sclerosis - RebiDose(TM) has Been Developed With the Goal to Simplify the Rebif(R...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

SRA - Frequently Asked Questions (FAQ)

What is the current Serono share price?
The current share price of Serono is US$ 0,00
What is the 1 year trading range for Serono share price?
Serono has traded in the range of US$ 0,00 to US$ 0,00 during the past year
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ALURAllurion Technologies Inc
US$ 6,3988
(72,94%)
3,43M
CLPRClipper Realty Inc
US$ 4,55
(11,79%)
1,23k
PNSTPinstripes Holdings Inc
US$ 0,42
(10,24%)
1,53k
TWLOTwilio Inc
US$ 125,00
(10,23%)
450,53k
GRNDGrindr Inc
US$ 18,24
(9,03%)
63,43k
SESSES AI Corporation
US$ 1,0301
(-6,35%)
1,71M
CVLGCovenant Logistics Group Inc
US$ 27,13
(-6,29%)
1,32k
PSFEPaysafe Limited
US$ 17,25
(-4,96%)
3,48k
DECDiversified Energy Company PLC
US$ 15,435
(-4,66%)
5,48k
VNCEVince Holding Corp
US$ 3,7205
(-4,60%)
212,11k
ALURAllurion Technologies Inc
US$ 6,3988
(72,94%)
3,43M
SESSES AI Corporation
US$ 1,0301
(-6,35%)
1,71M
RBLXRoblox Corporation
US$ 67,29
(0,27%)
1,68M
IPInternational Paper Company
US$ 58,58
(-0,03%)
1,68M
EWEdwards Lifesciences Corp
US$ 68,93
(0,00%)
1,51M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock